Media Release - 15 July 2008

PCB received an official notification from IPL on 14th July 2008 regarding an adverse Analytical Finding against Mohammad Asif- a player under contract with PCB. The specimen sample was processed in Switzerland under the umbrella of WADA.

PCB has a zero tolerance towards doping and condemns any such practice in all forms and manifestations. PCB is WADA compliant and has a comprehensive Anti Doping Policy which extends to all cricketers under the jurisdiction of PCB. Under clause 8.2.2 of Anti Doping Policy, PCB hereby suspends Mohammad Asif with immediate effect from participating in cricket including its organization, administration and promotion conducted by or under the auspices of PCB, ICC or ICC members until final decision which includes appeal.

As the sampling was done by IPL/BCCI, therefore under the ICC Anti Doping Code, the matter has been referred to IPL Drug Tribunal consisting of Dr. Ravi Bapat, Mr. Sunil Gavaskar and Mr. Shirish Gupte.

As per clause 16.2 of the PCB Anti Doping policy, the PCB is under obligation to recognize and enforce any penalty pursuant to the Anti Doping regulations of other ICC members or the ICC as if the PCB has imposed the penalty. PCB shall offer every reasonable assistance to ICC and other ICC members as they may require for the implementation and enforcement of their Anti Doping regulations.

PCB will be closely associated with the proceedings of BCCI/IPL Drugs Tribunal as under schedule 2 item 9 of the ICC Anti Doping Code. PCB is entitled to attend the proceedings of the Drug Tribunal as it has a legitimate interest in the outcome of the hearing.

This media release is being done in compliance of clause 8.2.5 of the PCB Anti Doping Policy.

Media Department

(Article: Copyright © 2008 Pakistan Cricket Board)